Search

everythingexperts & clinicslearnfaqsresearchcommunity

for

Search:↓

This review summarizes various treatment options for male androgenetic alopecia, noting that few demonstrate effective results, and reports no new clinical findings.

In this study, 32% of men continued taking finasteride for androgenetic alopecia after 1 to 3 years, but only a small percentage reported hair growth.

In this study, the use of micrografts for male pattern hair loss led to natural hair growth and patient satisfaction, despite low hair density and the potential need for multiple procedures.

This study from Finland suggests that insulin resistance might be the connecting factor between early-onset androgenetic alopecia and coronary artery disease in men under 35.

This article discusses male pattern baldness and the potential of androgen inhibitors, reporting on previous findings and the need for new preventive measures; it does not present new clinical results.

In this study, researchers found that changes in immune cell infiltration and immune-related gene expression may contribute to the immune microenvironment changes in male androgenetic alopecia.

This observational study found that 37% of male patients with androgenetic alopecia had a history of preceding COVID-19 infection, suggesting a potential link between the two.

This study identified CXXC5 as a key mediator of hair loss induced by PGD2 and DHT via suppression of the Wnt/β-catenin pathway, with implications for potential therapeutic targets.

This study suggests that a high frequency of androgenetic alopecia is associated with increased severity of COVID-19 in hospitalized patients.

This study observed that one-third of men with early-onset androgenetic alopecia had altered hormonal profiles, which were associated with increased insulin resistance and more severe hair loss.

This study found that testosterone impacts hair follicles from different scalp regions differently in male pattern androgenetic alopecia, challenging the belief that occipital scalp follicles are androgen-insensitive.

In this study, patients using the digitally enabled platform Keeps for male pattern hair loss treatment reported positive health outcomes, with 81% experiencing hair regrowth or ceasing hair loss after six months.

This source discusses the characteristics and clinical presentation of androgenetic alopecia, emphasizing the importance of early recognition and grading for administering therapy and the role of trichoscopy in diagnosis and monitoring treatment response.

This study found that scalp melanoma in areas with androgenetic alopecia presents with more frequent detrimental mutations and may have a poorer prognosis due to late diagnosis linked to hair concealment.

This case report describes a 54-year-old female erroneously treated for androgenetic alopecia with no improvement, later diagnosed with alopecia areata incognito through histopathological evaluation and appropriately treated.

In this study, androgenetic alopecia patients exhibited more nailfold capillary abnormalities, suggesting a potential link between microcirculation issues and the condition.

This study developed a deep learning framework and quantitative model that accurately predict basic and specific classification in male androgenetic alopecia by analyzing trichoscopic images.

This study found a higher prevalence of metabolic syndrome among young male patients with androgenic alopecia compared to age-matched controls.

This study found that high serum alarin levels were linked to both androgenetic alopecia and metabolic syndrome, increasing with the severity of AGA.

This study found no significant association between androgenetic alopecia and psychosocial well-being among middle-aged men in the Northern Finland Birth Cohort.

This study found no significant epidemiological association between male androgenetic alopecia and severe Covid-19, but suggests a potential shared biological basis in specific pathways.

This study concluded that smoking, stress, obesity, family history, exercise, hypertension, and unbalanced diet are significant non-genetic factors associated with androgenetic alopecia in Egyptian males.

This study found that vitamin D plays a major role in the premature onset of androgenetic alopecia.

This study did not report conclusive results on whether a higher dose of platelets in platelet-rich plasma treatment impacts hair density, emphasizing the need for further evaluation of the trial details.

In this randomized clinical trial, researchers reported that both topical and systemic finasteride treatments were similarly effective in increasing hair counts and terminal hair in men with androgenic alopecia after more than 3 months of follow-up.

This study found that men with androgenetic alopecia had a higher frequency of fatty liver disease compared to those without hair loss.

This study found that specific junctional proteins are significantly downregulated in balding regions of the scalp in men with androgenetic alopecia, suggesting disrupted cell communication may play a role in hair loss.

This study found that women had better knowledge and interest in androgenetic alopecia than men, especially about its definition and normal hair loss rates, but both sexes struggled with understanding its etiology and symptoms.

This study found that patients with androgenetic alopecia, particularly those with a U pattern, are prone to insulin resistance, with high fasting blood sugar and triglyceride values.

This study found that topical cetirizine 1% may be effective in treating androgenetic alopecia in men, with some patients experiencing new hair growth compared to none in the placebo group.